Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48777 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.45193 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.45524 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.39267 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39342 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48507 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46833 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43457 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.4334 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.44662 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.43746 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.4314 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.44491 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.44514 | 19 |